72
Participants
Start Date
February 26, 2024
Primary Completion Date
February 26, 2025
Study Completion Date
March 26, 2025
docosahexaenoic acid (DHA)
72 healthy participants will be divided into 6 groups and receive varying amounts of DHA (0mg, 100mg, 200mg, 400mg, 800mg and 1000mg) over the course of 8 weeks.
soybean oil placebo
72 healthy participants will be divided into 6 groups and receive varying amounts of DHA (0mg, 100mg, 200mg, 400mg, 800mg and 1000mg) over the course of 8 weeks. The 0mg group will receive only placebos.
Clinical Nutrition and Risk Factor Modification Centre, Toronto
Unity Health Toronto
OTHER
University of Toronto
OTHER